Clinical Trials Information for Researchers - Penn State Cancer Institute
Clinical Trials Information for Researchers
Clinical Trials Regulation Overview
Penn State Cancer Institute offers a number of clinical trials targeting different types of cancer.
Researchers interested in seeing currently open or recruiting trials can browse these categories:
Clinical Trials Office Overview
About the Clinical Trials Office
Penn State Cancer Institute's Clinical Trials Office enhances, fosters and promotes organized, high-quality clinical research.
About the Protocol Review Committee (PRC)
Cancer related clinical trials conducted by Penn State Health and Penn State College of Medicine investigators must be reviewed by the Protocol Review Committee. This website provides investigators with the resources, tools and forms needed to submit a cancer-related study for review. Investigators should carefully review the meeting schedule to ensure studies are reviewed in a timely manner.
About the Data and Safety Monitoring Review Committee (DSMC)
As a key element of the PSCI Data and Safety Monitoring Plan, the PSCI Data and Safety Monitoring Committee (DSMC) serves as the Data and Safety Monitoring Board (DSMB) of record for all cancer-related interventional clinical trials that are investigator-initiated and do not have an approved external DSMC. Interventional non-therapeutic trials may also be assigned to the PSCI DSMC if the study design and intervention involve additional risk to subjects. PSCI DSMC is responsible for providing oversight for the monitoring of clinical trial participant safety in addition to the validity and integrity of study data. The DSMC website provides investigators with resources, tools and forms needed.